Uric acid: A surrogate of insulin resistance in older women

Maturitas

Volumn 59, Issue 1, 2008, Pages 55-61

  Chen, Liang Kung ^a,b   Lin, Ming Hsien ^a,b   Lai, Hsiu Yun ^a,b   Hwang, Shinn Jang ^a,b   Chiou, Shu Ti ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Hyperuricemia; Insulin resistance; Metabolic syndrome; Sex; Uric acid

Indexed keywords

URIC ACID;

ADULT; ANAMNESIS; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; COMMUNITY; FEMALE; GLOMERULUS FILTRATION RATE; HOMEOSTASIS; HUMAN; HYPERURICEMIA; INSULIN RESISTANCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PHYSICAL EXAMINATION; PREVALENCE; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TAIWAN; URIC ACID BLOOD LEVEL;

BODY MASS INDEX; CHRONIC DISEASE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INSULIN RESISTANCE; KIDNEY DISEASES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TAIWAN; URIC ACID;

EID: 38749154271     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2007.10.006     Document Type: Article

References (33)

1. Dobson A. Is raised serum uric acid a cause of cardiovascular disease or death?. Lancet 354 (1999) 1578
2. Kohn P.M., and Prozan G.B. Hyperuricemia. Relationship to hypercholesterolemia and acute myocardial infarction. JAMA 170 (1959) 1909-1915
3. Beard J.T. Serum uric acid and coronary heart disease. Am Heart J 106 (1983) 397-400
4. Torun M., Yardim S., Simsek B., and Burgaz S. Serum uric acid levels in cardiovascular diseases. J Clin Pharm Ther 23 (1998) 25-29
5. Bengtsson C., Lapidus L., Stendahl C., and Waldenstrom J. Hyperuricaemia and risk of cardiovascular disease and overall death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Acta Med Scand 224 (1988) 549-555
6. Liese A.D., Hense H.W., Lowel H., Doring A., Tietze M., and Keil U. Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization monitoring trends and determinants in cardiovascular diseases. Epidemiology 10 (1999) 391-397
7. Wannamethee S.G., Shaper A.G., and Whincup P.H. Serum urate and the risk of major coronary heart disease events. Heart 78 (1997) 147-153
8. The Coronary Drug Project Research Group. Serum uric acid: its association with other risk factors and with mortality in coronary heart disease. J Chron Dis 29 (1976) 557-569
9. Reunanen A., Takkunen I.I., Knekt P., and Aromaa A. Hyperuricemia as a risk factor for cardiovascular mortality. Acta Med Scand Suppl 668 (1982) 49-59
10. Culleton B.F., Larson M.G., Kannel W.B., and Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131 (1999) 7-13
11. Bonora E., Targher G., Zenere M.B., et al. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord 20 (1996) 975-980
12. Agamah E.S., Srinivasan S.R., Webber L.S., and Berenson G.S. Serum uric acid and its relation to cardiovascular disease risk factors in children and young adults from a biracial community: the Bogalusa Heart Study. J Lab Clin Med 118 (1991) 241-249
13. Muscelli E., Natali A., Bianchi S., et al. Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens 9 (1996) 746-752
14. DeFronzo R.A. The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia 21 (1981) 165-171
15. Zimmet P.Z. Kelly West Lecture 1991. Challenges in diabetes epidemiology-from west to the rest. Diabetes Care 15 (1992) 232-252
16. Liou T.L., Lin M.W., Hsiao L.C., et al. Is hyperuricemia another facet of the metabolic syndrome?. J Chin Med Assoc 69 (2006) 104-109
17. Chen L.K., Lin M.H., Chen Z.J., Hwang S.J., Tsai S.T., and Chiou S.T. The metabolic characteristics among subjects with impaired fasting glucose in I-Lan. Diabetes Res Clin Pract 71 (2006) 170-176
18. World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment (2000), WHO, Geneva
19. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetolofia 28 (1985) 412-419
20. Ferrannini E., and Balkau B. Insulin: in search of a syndrome. Diabet Med 19 (2002) 724-729
21. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
22. Chen T.H., Chiu Y.H., Luh D.L., et al. Community-based multiple screening model: design, implementation, and analysis of 42,387 participants. Cancer 100 (2004) 1734-1743
23. Wu X., Muzny D.M., Lee C.C., and Caskey C.T. Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol 34 (1992) 78-84
24. Fang J., and Alderman M.H. Serum uric acid and cardiovascular mortality. The NHANES I epidemiologic follow-up study. 1971-1992. JAMA 283 (2000) 2404-2410
25. Alderman M.H., Cohen H., Madhavan S., and Kivlighn S. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 34 (1999) 144-150
26. Freedman D.S., Williamson D.F., Gunter E.W., and Byers T. Relation of serum uric acid to mortality and ischemic heart disease. Am J Epidemiol 141 (1995) 637-644
27. Tuttle K., Short Robert, and Johnson R. Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol 87 (2001) 1411-1414
28. Mikkelsen W.M., Dodge H.J., and Valkenburg H. The distribution of serum uric acid values in a population unselected as to gout or hyperuricemia: Tecumseh, Michigan, 1959-1960. Am J Med 39 (1965) 242-251
29. Ferris T.F., and Gorden P. Effect of angiotensin and norepinephrine upon urate clearance in man. Am J Med 4 (1968) 359-365
30. Ames B.N., Cathcart R., Schwiers E., and Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-causing aging and cancer: a hypothesis. Proc Natl Acad Sci USA 78 (1981) 6853-6862
31. Davies K.J., Sevanian A., Muakkassah-Kelly S.F., and Hochstein P. Uric acid-iron ion complexes: a new aspect of the anti-oxidant functions of uric acid. Biochem J 235 (1986) 747-754
32. Simie M.G., and Jovanovic S.V. Antioxidation mechanisms of uric acid. J Am Chem Soc 111 (1989) 5778-5782
33. Nieto F.J., Iribarren C., Gross M.D., Comstock G.W., and Cutler R.G. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?. Atherosclerosis 148 (2000) 131-139